Approval · Notice of Compliance 16813 · 2015
SOLIRIS: Notice of Compliance 16813
Issued April 20, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16813
- Date
- April 20, 2015
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additional drug substance and drug product manufacturing sites
- Therapeutic class
- Complement inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SOLIRIS | 02322285 | Marketed |
Medicinal ingredients
- ECULIZUMAB 10 MG per ML